PYXIS ONCOLOGY INC (PYXS) Stock Analyst Earnings Estimates
NASDAQ:PYXS - Nasdaq - US7473241013 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A -100.00% | N/A | N/A | N/A 129.80% | N/A 446.26% | N/A 169.41% | N/A 101.18% | N/A 46.81% | ||||||
| EBITDA YoY % growth | -2.88M | -12.42M -331.25% | -69.07M -456.12% | -122.77M -77.75% | -80.269M 34.62% | N/A -81.68% | N/A -46.35% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -2.88M | -12.89M -347.57% | -69.72M -440.88% | -123.48M -77.11% | -82.196M 33.43% | N/A 11.31% | N/A -33.46% | N/A -17.25% | N/A -57.59% | N/A -0.56% | N/A 21.41% | N/A 98.62% | N/A 11,607.38% | N/A 102.30% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -3.62 19.34% | -1.85 48.90% | N/A 39.82% | N/A -19.90% | N/A 5.25% | N/A -19.23% | N/A -0.23% | N/A 35.55% | N/A 112.57% | N/A 1,236.67% | N/A 66.08% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.34 -2.00% | -0.34 -469.50% | -0.33 -12.55% | -0.31 12.57% | -0.31 6.82% | -0.31 9.85% | -0.31 4.22% | -0.32 -5.33% | -0.33 -5.53% | -0.34 -9.27% | -0.34 -7.67% | -0.35 -7.59% |
| Revenue Q2Q % growth | -100.00% | N/A | N/A | N/A | N/A | N/A | N/A | 2.887M | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -22.951M -29.18% | -24.614M -339.14% | -24.748M -23.54% | -25.394M -6.90% | -25.548M -11.32% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.35 37.50% | -0.32 | -0.03 | -9.51% |
| Q2 2024 Q2Q % growth | -0.29 29.27% | -0.33 | 0.04 | 12.33% |
| Q1 2024 Q2Q % growth | -0.06 89.09% | -0.25 | 0.19 | 75.69% |
| Q4 2023 Q2Q % growth | -0.33 67.33% | -0.48 | 0.15 | 31.89% |
| Q3 2023 Q2Q % growth | -0.56 34.12% | -0.52 | -0.04 | -8.36% |
| Q2 2023 Q2Q % growth | -0.41 48.10% | -0.66 | 0.25 | 37.92% |
| Q1 2023 Q2Q % growth | -0.55 43.30% | -0.92 | 0.37 | 39.97% |
| Q4 2022 Q2Q % growth | -1.01 48.99% | -0.95 | -0.06 | -6.56% |
| Q3 2022 Q2Q % growth | -0.85 90.51% | -0.83 | -0.02 | -2.44% |
| Q2 2022 Q2Q % growth | -0.79 | -0.78 | -0.01 | -1.64% |
| Q1 2022 Q2Q % growth | -0.97 | -0.62 | -0.35 | -56.03% |
| Q4 2021 Q2Q % growth | -1.98 | -0.37 | -1.61 | -431.47% |
| Q3 2021 Q2Q % growth | -8.96 | -0.52 | -8.44 | -1,618.20% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | 16.146M | 4.208M | 11.938M | 283.70% |
| Q4 2023 Q2Q % growth | 170.003K | -170.003K | -100.00% | |
| Q2 2023 Q2Q % growth | 637.5K | -637.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.76% | -23.36% | -0.39% | -7.35% |
| Revenue | N/A | -100% | 0% | 2.96% |